Chemours (CC) PT Lowered to $14 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Chemours (CC) PT Lowered to $11.50 at Jefferies
May 8, 2025 12:55 PM EDTJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $11.50 (from $20.00) while maintaining a Hold rating.
The analyst comments "Q1 EPS of $0.13 was $0.07 below consensus and $0.21 below our estimate. Supply chain distortions appear to be a near-term headwind, while a... More
